| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2017) |
Fasihah Taleo [Vanuatu] ; George Taleo [Vanuatu] ; Patricia M. Graves ; Peter Wood ; Sung Hye Kim [Fidji, Royaume-Uni] ; Masayo Ozaki [Fidji] ; Hayley Joseph ; Brian Chu [États-Unis] ; Alex Pavluck [États-Unis] ; Aya Yajima [Philippines] ; Wayne Melrose ; Kazuyo Ichimori [Suisse, Japon] ; Corinne Capuano [Fidji] | Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu |
| 000127 (2016) |
Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie] | Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys. |
| 000241 (2015) |
Israt Hafiz [Royaume-Uni] ; Patricia Graves [Australie] ; Rouseli Haq [Bangladesh] ; Meerjady Sabrina Flora [Bangladesh] ; Louise A. Kelly-Hope [Royaume-Uni] | Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration. |
| 000242 (2015) |
Maria P. Rebollo [Royaume-Uni] ; Khalfan A. Mohammed ; Brent Thomas [Royaume-Uni] ; Shaali Ame [Tanzanie] ; Said Mohammed Ali ; Jorge Cano [Royaume-Uni] ; Alba Gonzalez Escalada [Espagne] ; Moses J. Bockarie [Royaume-Uni] | Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted? |
| 000296 (2014) |
Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. Taylor | Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience. |
| 000304 (2014) |
David H. Molyneux ; Adrian Hopkins [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Louise A. Kelly-Hope | Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms |
| 000370 (2013) |
Brajendra K. Singh [États-Unis] ; Moses J. Bockarie [Royaume-Uni] ; Manoj Gambhir [Royaume-Uni] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch [États-Unis] ; James Kazura [États-Unis] ; Edwin Michael [États-Unis] | Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea |
| 000381 (2013) |
Daniel Engelman [Australie] ; Diana L. Martin [États-Unis] ; Roderick J. Hay [Royaume-Uni] ; Olivier Chosidow [France] ; James S. Mccarthy [Australie] ; L Claire Fuller [Royaume-Uni] ; Andrew C. Steer [Australie] | Opportunities to investigate the effects of ivermectin mass drug administration on scabies |
| 000395 (2013) |
Joseph B. Koroma [Sierra Leone, Burkina Faso, Royaume-Uni] ; Santigie Sesay [Sierra Leone] ; Mustapha Sonnie [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Foday Sahr [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni] | Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone |
| 000396 (2013) |
Taniawati Supali [Indonésie] ; Yenny Djuardi [Indonésie] ; Mark Bradley [Royaume-Uni] ; Rahmah Noordin [Malaisie] ; Paul Rückert [Indonésie] ; Peter U. Fischer [États-Unis] | Impact of Six Rounds of Mass Drug Administration on Brugian Filariasis and Soil-Transmitted Helminth Infections in Eastern Indonesia |
| 000423 (2013) |
Alison Krentel [États-Unis, Royaume-Uni] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis] | A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis |
| 000486 (2012) |
Melissa Parker [Royaume-Uni] ; Tim Allen [Royaume-Uni] | WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM
NORTHERN COASTAL TANZANIA |
| 000494 (2012) |
Khalfan A. Mohammed ; Rinki M. Deb [Royaume-Uni] ; Michelle C. Stanton [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] | Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis - a rapid assessment methodology to assess impact |
| 000510 (2012) |
Joseph B. Koroma [Sierra Leone, Royaume-Uni] ; Momodu M. Bangura [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Mohamed S. Bah [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni] | Lymphatic filariasis mapping by Immunochromatographic Test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone |
| 000600 (2011) |
Ruth A. Ashton [Ouganda, Royaume-Uni] ; Daniel J. Kyabayinze [Ouganda] ; Tom Opio [Ouganda] ; Anna Auma [Ouganda] ; Tansy Edwards [Royaume-Uni] ; Gabriel Matwale [Ouganda] ; Ambrose Onapa [Ouganda] ; Simon Brooker [Royaume-Uni, Kenya] ; Jan H. Kolaczinski [Ouganda, Royaume-Uni] | The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda |
| 000602 (2011) |
Sammy M. Njenga [Kenya] ; Charles S. Mwandawiro [Kenya] ; C Njeri Wamae [Kenya] ; Dunstan A. Mukoko [Kenya] ; Anisa A. Omar [Kenya] ; Masaaki Shimada [Kenya, Japon] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] | Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control |
| 000605 (2011) |
Daniel J. Tisch [États-Unis] ; Neal D. E. Alexander [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Benson Kiniboro [Papouasie-Nouvelle-Guinée] ; Henry Dagoro [Papouasie-Nouvelle-Guinée] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Moses J. Bockarie [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Michael P. Alpers [Papouasie-Nouvelle-Guinée, Australie] ; James W. Kazura [États-Unis] | Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea |
| 000925 (2008) |
Joshua S. Boateng [Royaume-Uni] ; Kerr H. Matthews [Royaume-Uni] ; Howard N. E. Stevens [Royaume-Uni] ; Gillian M. Eccleston [Royaume-Uni] | Wound healing dressings and drug delivery systems: A review |
| 000B06 (2006) |
C. Williams [Royaume-Uni] ; A. S. Highet [Royaume-Uni] | Drug‐induced delayed multiorgan hypersensitivity (DIDMOHS) |
| 000B40 (2005) |
Tim Oqueka [Allemagne] ; Taniawati Supali [Indonésie] ; Is Suhariah Ismid [Indonésie] ; Paul Rückert [Indonésie] ; Mark Bradley [Royaume-Uni] ; Peter Fischer [Allemagne, États-Unis] | Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia |
| 000C63 (2003) |
David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. Taylor | Mass drug treatment for lymphatic filariasis and onchocerciasis. |
